STING1 and ovarian cancer: Several experimental studies have reported the expression of cGAS and/or STING in human melanoma, colorectal cancer, Merkel cell carcinoma, and ovarian cancer (Xia et al., 2016a,b; de Queiroz et al., 2019; Liu et al., 2020).